Veracyte Stock Drops 54.30% the Day After Earnings Report
The pick
Veracyte (VCYT) had the biggest jump in trading volume compared with its usual level. About 11.4x its 30-day average changed hands. The stock fell 54.30%.
What happened
On November 4, 2026, Veracyte issued a press release with its results for the quarter ended September 30, 2026. The company also filed its quarterly report (Form 10-Q) on November 5.
In the same 8-K filing, Veracyte said it had started a share repurchase program. The program lets it buy back up to $100.0 million of its common stock over one year. The company said it is not required to buy any set number of shares and can change or stop the program at any time.
The 8-K does not state a reason for the stock's move.
Sources: [8-K filing] [10-Q filing]
What news reports said
Yahoo Finance reported that Veracyte lowered its near-term expectations for its Decipher Prostate test after volume came in below management's forecast [Yahoo Finance].
Another Yahoo Finance article reported that Veracyte posted $151.8 million in third-quarter revenue and authorized a $100 million buyback. It also reported that the company reset its 2027 growth expectations amid competitive pressure and heavier commercial investment. Yahoo Finance also reported that revenue grew 15% in the quarter. [Yahoo Finance] [Yahoo Finance]
The Motley Fool reported that Decipher volume fell short as Veracyte closed a $150M deal. [The Motley Fool]
None of these reports says it caused the stock's drop.
The numbers
Previous close: $52.52
Close: $24.00
Change: -54.30%
Volume: 14,964,638
30-day average volume: 1,308,017
Volume multiple: 11.4x
Behind the move: an earnings report
VCYT's most unusual trading day in 15 months
Its sector (Health Care, XLV) moved -2.50% that day
Pro: VCYT has had 8+ earlier days at 5x+ normal volume since 2016. Pro members see what it did over the next 5 and 20 trading days after each one. See Pro
More coverage
Why Is Veracyte Stock Sinking Thursday? (Benzinga)
Veracyte: Q3 Earnings Snapshot (Yahoo Finance)
Pro: 9 more stocks made Thursday's unusual-volume top 10, the next one at 10.0x its normal level. Pro members can also test any setup in plain English on every U.S. stock since 2016 ("what happened after stocks traded 11x their normal volume?"), and get the full top 10 every morning plus intraday alerts on big moves. 25 of 25 founding spots left: $9/month, locked in for as long as you stay ($14 after Dec 31 or when the spots are gone). Claim a founding spot